Nanobac Pharmaceuticals Management
Management criteria checks 2/4
We currently do not have sufficient information about the CEO.
Key information
Jon Stanton
Chief executive officer
n/a
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | 23.7yrs |
| CEO ownership | n/a |
| Management average tenure | 20.8yrs |
| Board average tenure | 20.8yrs |
Recent management updates
No updates
Recent updates
CEO
Jon Stanton (61 yo)
23.7yrs
Tenure
Mr. John M. Stanton, also known as Jon, has been the Chairman and Chief Financial Officer of Nanobac Pharmaceuticals, Incorporated since March 2001, Chief Executive Officer since July 23, 2004 and also ser...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chairman | 23.7yrs | no data | no data | |
| Director of Clinical Research | no data | US$87.50k | no data | |
| Co-Founder | 20.8yrs | no data | no data | |
| Chief Science & Research Officer and MD of Nanobac OY | 20.8yrs | no data | no data |
20.8yrs
Average Tenure
Experienced Management: NNBP's management team is seasoned and experienced (20.8 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chairman | 23.7yrs | no data | no data | |
| Director of Clinical Research | 18.7yrs | US$87.50k | no data | |
| Director | 20.8yrs | US$8.87k | no data | |
| Independent Director | 20.8yrs | no data | no data | |
| Member of Scientific Advisory Board | no data | no data | no data |
20.8yrs
Average Tenure
74yo
Average Age
Experienced Board: NNBP's board of directors are seasoned and experienced ( 20.8 years average tenure).